Skip to main content
Contact Us
Subscribe
E-Edition
69°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Fulgent Genetics Inc
(NQ:
FLGT
)
20.27
+0.24 (+1.20%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Fulgent Genetics Inc
< Previous
1
2
3
4
Next >
FLGT Stock Earnings: Fulgent Genetics Beats EPS, Misses Revenue for Q1 2024
May 03, 2024
FLGT stock results show that Fulgent Genetics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
The 3 Best Digital Health Stocks for Personalized Medicine
November 25, 2023
Digital health stocks are becoming increasingly relevant as more and more people seek greater control over their health.
Via
InvestorPlace
Earnings Scheduled For November 3, 2023
November 03, 2023
Companies Reporting Before The Bell • Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per share on revenue of $32.83 million.
Via
Benzinga
Earnings Preview: Fulgent Genetics
November 02, 2023
Via
Benzinga
Why Is Fulgent Genetics Stock Moving Higher Today?
August 04, 2023
Fulgent Genetics Inc (NASDAQ: FLGT) reported Q2 sales of $68 million, beating the consensus estimate of $62.68 million.<
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 29, 2023
Via
Benzinga
Earnings Scheduled For August 4, 2023
August 04, 2023
Companies Reporting Before The Bell • WPP (NYSE:WPP) is projected to report earnings for its first quarter. • Anglogold Ashanti (NYSE:AU) is likely to report earnings for its first quarter.
Via
Benzinga
Earnings Outlook For Fulgent Genetics
August 03, 2023
Via
Benzinga
Fulgent Genetics Earnings Perspective: Return On Capital Employed
May 19, 2023
Via
Benzinga
Got $2,500? This Dirt Cheap Growth Stock Could Be Worth Buying Hand Over Fist
June 06, 2023
Fulgent is moving past its pandemic-era business, and that's a good thing.
Via
The Motley Fool
Better Diversified Biotech Stock: 23andMe vs. Fulgent Genetics
May 23, 2023
Neither has a traditional business model, but that could be an asset for both.
Via
The Motley Fool
2 Undervalued Stocks to Buy for Potentially Massive Gains in the Next 10 Years
May 23, 2023
Both are experiencing a bit of a hangover from declining COVID-19-related sales.
Via
The Motley Fool
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 05, 2023
Via
Benzinga
Fulgent Genetics: Q1 Earnings Insights
May 05, 2023
Via
Benzinga
7 Stocks to Buy to Bag Big-Time Returns in Q2
April 16, 2023
If you’re willing to take huge risks, these stocks to buy might yield you massive gains in Q2 – or you could be looking at a tax write-off.
Via
InvestorPlace
Looking Into Fulgent Genetics's Return On Capital Employed
March 06, 2023
Via
Benzinga
Where Fulgent Genetics Stands With Analysts
December 08, 2022
Via
Benzinga
5 Value Stocks In The Healthcare Sector
December 05, 2022
Via
Benzinga
Fulgent Genetics's Return on Invested Capital Insights
December 01, 2022
Via
Benzinga
Earnings Scheduled For May 5, 2023
May 05, 2023
Companies Reporting Before The Bell • CNH Industrial (NYSE:CNHI) is estimated to report quarterly earnings at $0.32 per share on revenue of $5.08 billion.
Via
Benzinga
Preview: Fulgent Genetics's Earnings
May 04, 2023
Via
Benzinga
1 Green Flag and 1 Red Flag for Fulgent Genetics After Earnings
November 24, 2022
Strong core business growth was overshadowed in Q3 by an acquisition.
Via
The Motley Fool
4 Analysts Have This to Say About Fulgent Genetics
November 18, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
October 19, 2022
On Wednesday, 200 companies hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
January 06, 2023
During Friday's trading, 71 companies set new 52-week lows.
Via
Benzinga
Which Is the Better Buy: Vertex or Invitae?
December 16, 2022
Is Vertex worth its lofty valuation compared to Invitae?
Via
The Motley Fool
My Top 7 Strong Conviction Buys for 2023
December 15, 2022
Companies that are down on their luck this year are in strong contention for conviction buys for 2023 as they rebound.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
November 18, 2022
Upgrades
Via
Benzinga
Earnings Preview: Fulgent Genetics
November 04, 2022
Fulgent Genetics (NASDAQ:FLGT) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that Fulgent...
Via
Benzinga
A Look Into Healthcare Sector Value Stocks
October 24, 2022
What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.